Men and postmenopausal women need only around 8 mg a day, while premenopausal women need 18 mg a day.
男性和绝经后妇女每天只需8毫克，而绝经前的妇女每天则需18毫克。
Hereditary breast cancer commonly occurs in premenopausal women.
遗传性乳癌通常发生于绝经前妇女。
A study of the drug focused on its effects upon premenopausal women.
该药物的一项研究关注的是它对绝经前妇女的作用。
This association was not observed among premenopausal African-American women.
而在绝经前的美国黑人妇女中未发现这一相关性。
Conclusions: Postmenopausal endometriosis was most likely the persistence of premenopausal endometriosis.
结论：绝经后内异症很可能是绝经前就存在的。
Objectives To investigate the correlation among estrogen, antioxidation and atherosclerotic plaque in premenopausal and postmenopausal women.
摘要目的：探讨绝经前后妇女雌激素水平、抗氧化能力与动脉粥样硬化斑块的关系。
Conclusions LH-RH analog is effective and safe for premenopausal breast cancer with low adverse reaction and its administration method is easy.
结论LH - RH类似物治疗绝经前乳腺癌疗效肯定，副作用小，给药方便。
Objective: To assess the protective effect of goserelin on the ovarian function of premenopausal patients with breast cancer during chemotherapy.
目的：评估戈舍瑞林对绝经前乳腺癌患者辅助化疗期间卵巢功能的保护作用。
The postmenopausal women had significantly higher levels of bone turnover markers than premenopausal women and they correlate negatively to bone mass.
绝经后骨转换指标明显高于绝经前，与骨量呈负相关。
Polycystic ovary syndrome, the most common hormonal disorder in premenopausal women in the U. S., is caused by the disruption of the reproductive cycle.
多囊卵巢综合征是美国绝经前期妇女最常见的内分泌紊乱，因生殖周期中断引起。
LHRH agonists provide an additional class of agents for treatment of premenopausal women with hormone-receptor-positive breast cancer. Optimum duration of use is unknown.
LHRH激动剂为激素受体阳性的绝经前乳腺癌女性患者提供了一种附加的治疗手段。最佳服用时限仍未知。
Objective To investigate the association of lipoprotein receptor-related protein 5(LRP5) gene Q89R, A1330V polymorphism with bone mineral density(BMD) in premenopausal Northern Chinese women.
目的探讨中国北方绝经前妇女低密度脂蛋白受体相关蛋白5（LRP5）基因Q89R、A1330V多态性与骨密度关系。
PURPOSE Premenopausal women with breast cancer receiving adjuvant chemotherapy are at risk for amenorrhea.
目的：绝经前女性乳腺癌患者接受辅助化疗存在闭经风险。
PURPOSE Premenopausal women with breast cancer receiving adjuvant chemotherapy are at risk for amenorrhea.
目的：绝经前女性乳腺癌患者接受辅助化疗存在闭经风险。
应用推荐